Human genome editing in heart diseaseNature.comMitalipov and colleagues sought to demonstrate that heterozygous gene mutations can be corrected in human gametes or early embryos. The investigators used human zygotes produced using sperm from a donor wi… Continue reading
|
Monsanto, ToolGen reach agreement on CRISPR technology
Wallace’s Farmer The license provides Monsanto with access to ToolGen’s comprehensive suite of CRISPR intellectual property for use in plants. This agreement further expands Monsanto’s portfolio of gene-editing tools that can be used to develop improved and sustainable … |
KSTP.com |
Inside Your Health: The DNA Editor ‘Crispr‘
KSTP.com There have been major advancements within the past couple weeks to a technology that edits DNA. The technique is referred to as “crispr” — and it has gripped scientists across the world over the past few years. Advertisement. KSTP medical expert … |
KSTP.com |
Inside Your Health: The DNA Editor ‘Crispr‘
KSTP.com There have been major advancements within the past couple weeks to a technology that edits DNA. The technique is referred to as “crispr” — and it has gripped scientists across the world over the past few years. Advertisement. KSTP medical expert … |
|
Promise of Immunotherapy Amid Health Care’s Uncertain Future
LWW Journals Invited speakers at a Congressional briefing on Capitol Hill in Washington, D.C., explored the benefits of immunotherapy drugs and the bright future immunotherapies represent for cancer patients. The briefing was sponsored by the American Association … |
Madison.com |
The Netherlands Is Taking Aim at One of America’s Fastest-Growing Sectors
Madison.com DARPA is the world’s leading investor in synthetic biology. The United States has a network of national labs investigating various scientific questions. And several large biotech companies have established their own venture capital funds to fund new … |